Summary: Mike Riley, President, Catalent Biologics, will discuss the latest trends in ADC discovery and development, with a focus on how next generation pipelines are being shaped by payload and linker chemistry innovations, including those from Catalent’s award-winning SMARTag® ADC platform.
Summary: In this webinar Endpoints Editor, John Carroll sits down with Catalent CEO, Alessandro Maselli to talk about the year ahead, offering their projections for what 2023 holds in store for the biopharma industry
In this webinar, experts discuss how companies with promising HPAPIs can overcome development challenges in order to bring innovative medicines to market.
In this webinar experts will discuss the challenges cell and gene therapy innovators face and how experts resolve these barriers through adopting technology and strategy that drive an optimized plasmid production process and supply.
In this webinar experts will discuss a unique approach that integrates advanced formulation expertise with on-demand Phase 1 clinical manufacturing, adaptive clinical testing, statistical and regulatory support to help achieve flexible and efficient First-in-Human studies and fast development for challenging molecules.
